Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amphastar Pharmaceuticals Inc AMPH

Healthcare
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed... see more

Recent & Breaking News (NDAQ:AMPH)

Q3 Trading Statement

UK Regulatory news services, from the LSE August 4, 2016

Interim Management Statement

UK Regulatory news services, from the LSE August 4, 2016

Fundraising & Acquisitions

UK Regulatory news services, from the LSE August 4, 2016

Acquisition

UK Regulatory news services, from the LSE August 4, 2016

HALO signs MoU with ENGIE

UK Regulatory news services, from the LSE August 4, 2016

Completion of Placing

UK Regulatory news services, from the LSE August 4, 2016

Result of Rump Placing

UK Regulatory news services, from the LSE August 4, 2016

Half Yearly Report

UK Regulatory news services, from the LSE August 4, 2016

Amphastar Pharmaceuticals, Inc. Purchases International Medication Systems (UK) Limited from UCB PHARMA GmbH

GlobeNewswire August 4, 2016

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2016

GlobeNewswire August 1, 2016

Project Updates

UK Regulatory news services, from the LSE July 27, 2016

Result of AGM

UK Regulatory news services, from the LSE July 27, 2016

Form 8.3 - Arm Holdings Plc

UK Regulatory news services, from the LSE July 27, 2016

Main Securities Market Notice

UK Regulatory news services, from the LSE July 20, 2016

Director/PDMR Shareholding

UK Regulatory news services, from the LSE July 20, 2016

Proposed acquisitions and final results

UK Regulatory news services, from the LSE June 30, 2016

Amphastar Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference

GlobeNewswire June 3, 2016